All living cells require a continuous supply of energy to maintain their structure, grow, and carry out essential biological processes. This energy is mainly produced through the controlled breakdown of nutrients such as carbohydrates, fats, and proteins. At the center of this metabolic network lies a key biochemical pathway known as the Krebs cycle, also called the citric acid cycle or tricarboxylic acid (TCA) cycle.
The Krebs cycle does not directly produce large amounts of ATP, but it plays a critical role by generating high-energy electron carriers that fuel the final stage of cellular respiration, the electron transport chain. In addition, many of its intermediates are used as building blocks for important biosynthetic pathways, making the cycle essential not only for energy production but also for cell growth and maintenance.
In this article, we will first explain what the Krebs cycle is and where it occurs in the cell, then walk through its main reaction steps, discuss how the cycle is regulated, and finally explore its biological and clinical importance, including its relevance in cancer metabolism.
What Is the Krebs Cycle?
The Krebs cycle is a cyclic series of enzyme-catalyzed chemical reactions that plays a central role in cellular respiration. It functions as the main pathway through which carbon atoms from nutrients are fully oxidized, allowing the cell to extract high-energy electrons that will later be used to produce ATP. Because of its central position in metabolism, the Krebs cycle connects carbohydrate, lipid, and protein metabolism into a single integrated system.
Definition and Historical Background
The Krebs cycle is also known as the citric acid cycle or the tricarboxylic acid (TCA) cycle, names that reflect the chemical nature of its intermediates. It was first described in 1937 by the biochemist Hans Adolf Krebs, who identified the cyclic sequence of reactions that oxidize acetate derived from nutrients.
In this pathway, a two-carbon molecule (acetyl-CoA) enters the cycle and combines with a four-carbon molecule (oxaloacetate) to form citrate, a six-carbon compound. Through a series of reactions, citrate is progressively oxidized, releasing carbon dioxide, while oxaloacetate is regenerated to begin another round of the cycle. This recycling of intermediates is what makes the pathway a true metabolic cycle.
Cellular Location of the Krebs Cycle
In eukaryotic cells, the Krebs cycle takes place in the mitochondrial matrix, the inner compartment of the mitochondrion where many metabolic enzymes are concentrated. This location allows the reduced cofactors produced by the cycle, mainly NADH and FADH₂, to be rapidly transferred to the nearby electron transport chain located in the inner mitochondrial membrane.
In prokaryotic cells, which lack mitochondria, the Krebs cycle occurs in the cytoplasm. Even without membrane-bound organelles, bacteria still use the same basic reactions to generate reducing power and metabolic intermediates, highlighting the evolutionary conservation of this pathway.
Because the Krebs cycle depends on functional mitochondria in eukaryotic cells, any damage to mitochondrial structure or enzyme activity can significantly impair cellular energy metabolism and overall cell viability.
Overall Purpose of the Krebs Cycle
The main function of the Krebs cycle is not to produce ATP directly, but to generate high-energy electron carriers that drive ATP synthesis during oxidative phosphorylation. For each molecule of acetyl-CoA that enters the cycle, the pathway produces:
- 3 molecules of NADH
- 1 molecule of FADH₂
- 1 molecule of GTP (or ATP)
- 2 molecules of CO₂ as waste products
NADH and FADH₂ carry electrons to the electron transport chain, where their energy is converted into a large amount of ATP. Therefore, the Krebs cycle acts as a major supplier of reducing equivalents for cellular energy production.
In addition to its role in energy metabolism, the Krebs cycle also serves as a biosynthetic hub. Several of its intermediates are used as precursors for the synthesis of amino acids, nucleotides, fatty acids, and heme. For this reason, the cycle is described as an amphibolic pathway, meaning it participates in both catabolic (energy-producing) and anabolic (biosynthetic) processes.
Steps of the Krebs Cycle: From Citrate to Oxaloacetate
Once acetyl-CoA enters the Krebs cycle, it is gradually oxidized through a sequence of enzyme-catalyzed reactions. During these steps, carbon atoms are released as carbon dioxide, and energy is captured in the form of reduced cofactors (NADH and FADH₂) and one molecule of GTP (or ATP). By the end of the cycle, the four-carbon molecule oxaloacetate is regenerated, allowing the pathway to continue.
For simplicity, the reactions can be grouped into three functional phases: entry and citrate formation, oxidative decarboxylation, and regeneration of oxaloacetate.
Entry Step: Formation of Citrate
The cycle begins when the two-carbon acetyl group from acetyl-CoA combines with the four-carbon molecule oxaloacetate to form citrate, a six-carbon compound. This reaction is catalyzed by the enzyme citrate synthase.
This step is important for several reasons:
- It commits acetyl-CoA to the Krebs cycle
- It is highly exergonic and essentially irreversible
- It is a major point of metabolic regulation
After citrate is formed, it undergoes a rearrangement to produce isocitrate, catalyzed by the enzyme aconitase. This rearrangement does not change the number of carbon atoms but prepares the molecule for the oxidation reactions that follow.
Carbon Rearrangement and Oxidative Decarboxylation
Isocitrate is first oxidized and then decarboxylated by the enzyme isocitrate dehydrogenase, producing:
- α-ketoglutarate (a five-carbon molecule)
- CO₂
- NADH
This reaction represents the first loss of carbon from the cycle and is one of the main regulatory steps, responding strongly to the cell’s energy needs.
Next, α-ketoglutarate is converted into succinyl-CoA by the α-ketoglutarate dehydrogenase complex. This reaction is similar to the conversion of pyruvate to acetyl-CoA and produces:
- CO₂
- NADH
- A high-energy thioester bond in succinyl-CoA
At this point, the two carbons that originally entered the cycle as part of acetyl-CoA have been released as carbon dioxide, even though they are not necessarily the same carbons added in the current cycle turn due to molecular rearrangements.
Regeneration of Oxaloacetate
The remaining steps of the cycle focus on regenerating oxaloacetate, the molecule required to accept another acetyl-CoA and continue the cycle.
First, succinyl-CoA is converted into succinate by the enzyme succinyl-CoA synthetase. This step is unique because it produces energy directly through substrate-level phosphorylation, generating:
- GTP (or ATP)
Next, succinate is oxidized to fumarate by succinate dehydrogenase, producing:
- FADH₂
This enzyme is embedded in the inner mitochondrial membrane and also functions as part of the electron transport chain, linking the Krebs cycle directly to oxidative phosphorylation.
Fumarate is then converted into malate by fumarase, through the addition of a water molecule. Finally, malate is oxidized to regenerate oxaloacetate by malate dehydrogenase, producing:
- NADH
Regulation of the Krebs Cycle and Metabolic Control
The Krebs cycle must continuously adapt to the energy demands of the cell. When energy is needed, the cycle speeds up to produce more NADH and FADH₂ for ATP generation. When energy is abundant, the cycle slows down to avoid unnecessary oxidation of nutrients. This tight control is achieved mainly through regulation of key enzymes and through signals that reflect the cell’s metabolic state.
Key Regulatory Enzymes of the Cycle
Although many enzymes participate in the Krebs cycle, only a few are strongly regulated. These enzymes catalyze reactions that are essentially irreversible and therefore determine the overall rate of the cycle.
The most important regulatory enzymes are:
- Citrate synthase
Controls the entry of acetyl-CoA into the cycle. It is inhibited when citrate accumulates or when ATP levels are high, indicating that energy supply is sufficient. - Isocitrate dehydrogenase
This is one of the main rate-limiting steps of the cycle. It is activated by ADP and inhibited by ATP and NADH, making it highly sensitive to cellular energy status. - α-Ketoglutarate dehydrogenase complex
Regulates the conversion of α-ketoglutarate to succinyl-CoA. It is inhibited by its products (NADH and succinyl-CoA) and by high ATP levels, while calcium ions can activate it in tissues such as muscle during contraction.
By controlling these three enzymes, the cell can rapidly adjust the overall flux of the Krebs cycle in response to changing metabolic conditions.
Role of Energy Status and Redox Balance
The activity of the Krebs cycle is closely linked to the ratio of energy-rich and energy-poor molecules inside the cell. Two main indicators are used:
- ATP/ADP ratio → reflects energy availability
- NADH/NAD⁺ ratio → reflects the redox state of the cell
When ATP and NADH levels are high, the cell does not need to generate more energy, so key enzymes of the cycle are inhibited. This slows down the oxidation of acetyl-CoA and prevents excessive production of reducing equivalents.
In contrast, when ADP and NAD⁺ levels increase, it signals that ATP is being consumed. Under these conditions, the Krebs cycle is activated to increase NADH and FADH₂ production, which will drive ATP synthesis through the electron transport chain.
Importantly, the Krebs cycle depends indirectly on oxygen. If oxygen is limited, the electron transport chain slows down, NADH accumulates, and NAD⁺ becomes scarce. This lack of NAD⁺ inhibits several steps of the cycle, reducing its activity even if acetyl-CoA is available.
Integration with Other Metabolic Pathways
The Krebs cycle does not function in isolation. It is tightly connected to many other metabolic pathways, allowing cells to balance energy production with biosynthesis.
Key points of integration include:
- Input pathways (cataplerotic flux):
- Glycolysis provides acetyl-CoA via pyruvate oxidation
- Fatty acid β-oxidation produces acetyl-CoA
- Amino acid degradation feeds into various intermediates
- Output pathways (anabolic use of intermediates):
- α-Ketoglutarate and oxaloacetate for amino acid synthesis
- Citrate for fatty acid and cholesterol synthesis
- Succinyl-CoA for heme biosynthesis
When intermediates are withdrawn for biosynthesis, they must be replenished to keep the cycle functioning. This is achieved through anaplerotic reactions, such as the conversion of pyruvate to oxaloacetate by pyruvate carboxylase. These reactions ensure that the cycle maintains sufficient intermediate levels to continue processing acetyl-CoA.
Biological and Clinical Importance of the Krebs Cycle
Beyond its classical role in energy metabolism, the Krebs cycle is essential for maintaining normal cellular function, supporting biosynthetic pathways, and regulating signaling processes. Because of this central role, disturbances in the cycle can contribute to a wide range of diseases, including cancer and mitochondrial disorders.
Central Role in Cellular Metabolism
The Krebs cycle is described as an amphibolic pathway, meaning it participates in both the breakdown of molecules to release energy and the synthesis of important cellular components.
Several intermediates of the cycle serve as precursors for key biosynthetic processes:
- Citrate can be exported from mitochondria and used for the synthesis of fatty acids and cholesterol.
- α-Ketoglutarate is a precursor for glutamate and other amino acids.
- Oxaloacetate is used to form aspartate, which contributes to nucleotide and amino acid synthesis.
- Succinyl-CoA is required for heme production, essential for hemoglobin and cytochromes.
Because these intermediates are continuously withdrawn for biosynthesis, the cell must replenish them through anaplerotic reactions. This tight coordination allows the Krebs cycle to balance energy production with the supply of building blocks needed for cell growth and maintenance.
In rapidly dividing cells, such as immune cells and tumor cells, this biosynthetic function becomes just as important as ATP generation.
Krebs Cycle and Cancer Metabolism
Cancer cells often show profound alterations in mitochondrial metabolism, including changes in Krebs cycle activity. While many tumors rely heavily on glycolysis (a phenomenon known as the Warburg effect), the Krebs cycle remains active and supports tumor growth through biosynthesis and redox balance.
Several Krebs cycle enzymes are now recognized as tumor suppressors or oncogenic drivers when mutated:
- Isocitrate dehydrogenase (IDH) mutations lead to the production of the oncometabolite 2-hydroxyglutarate, which alters gene expression through epigenetic mechanisms.
- Accumulation of succinate or fumarate due to enzyme defects can stabilize hypoxia-inducible factors (HIFs), promoting angiogenesis and metabolic reprogramming.
These metabolic changes contribute to:
- Increased cell proliferation
- Resistance to apoptosis
- Adaptation to low-oxygen environments
As a result, Krebs cycle metabolism is now considered an important target for cancer diagnostics and therapeutic development, linking classical biochemistry to modern precision oncology.
Diseases Related to Krebs Cycle Dysfunction
Defects in Krebs cycle enzymes or mitochondrial function can lead to serious metabolic and neurological disorders. Because tissues such as the brain and muscles have high energy demands, they are particularly sensitive to impaired oxidative metabolism.
Clinical consequences of Krebs cycle dysfunction may include:
- Developmental delay and neurological impairment
- Muscle weakness and exercise intolerance
- Lactic acidosis due to impaired oxidative metabolism
- Progressive neurodegenerative symptoms
Some inherited metabolic diseases are caused by mutations in enzymes such as fumarase or succinate dehydrogenase. In addition, mitochondrial dysfunction associated with aging, neurodegeneration, and chronic diseases often involves reduced efficiency of Krebs cycle activity.
Conclusion
The Krebs cycle stands at the heart of cellular metabolism, linking the breakdown of nutrients to the production of energy and essential biosynthetic precursors. By oxidizing acetyl-CoA and generating NADH and FADH₂, the cycle supplies the electron transport chain with the reducing power needed for efficient ATP synthesis. At the same time, its intermediates support the synthesis of amino acids, lipids, nucleotides, and heme, making it indispensable for cell growth and maintenance.
